By Anna C. Greene, PhD, NETRF Chief Scientific Officer In recent years, you may have seen headlines and commentaries suggesting that neuroendocrine cancers are “no longer rare.” These claims often point to rising diagnosis rates and the growing number of people living with neuroendocrine cancer. Those trends are important and should lead to greater attention, … Continue reading “Not Rare Anymore?” Why That Doesn’t Tell the Whole Story